| Firmenprofile / SWOT Reports angezeigte Produkte: 1 bis 50 (von 58308 insgesamt) |
| |
EU-Studie - Einzelhandel mit Fisch und Fischerzeugnissen
AIK - Kohlhaas & Partner
Konjunkturelle Rahmendaten, Einzelhandel mit Fisch und Fischerzeugnissen, 2008, nach Ländern der EU, Handels-Struktur und -Entwicklung, Anzahl der Unternehmen, Beschäftigten, Umsa
|
2011 |
480,00€ |
| |
EU-Studie - Versand- und Internet-Einzelhandel
AIK - Kohlhaas & Partner
Konjunkturelle Rahmendaten, Versand- und Internet-Einzelhandel, 2008, nach Ländern der EU, Handels-Struktur und -Entwicklung, Anzahl der Unternehmen, Beschäftigten, Umsatz, Warene
|
2011 |
480,00€ |
| |
EU-Studie - Einzelhandel mit Büchern
AIK - Kohlhaas & Partner
Konjunkturelle Rahmendaten, Einzelhandel mit Büchern, 2008, nach Ländern der EU, Handels-Struktur und -Entwicklung, Anzahl der Unternehmen, Beschäftigten, Umsatz, Wareneinsatz und
|
2011 |
480,00€ |
| |
EU-Studie - Einzelhandel mit Obst, Gemüse und Kartoffeln
AIK - Kohlhaas & Partner
Konjunkturelle Rahmendaten, Einzelhandel mit Obst, Gemüse und Kartoffeln, 2008, nach Ländern der EU, Handels-Struktur und -Entwicklung, Anzahl der Unternehmen, Beschäftigten, Umsa
|
2011 |
480,00€ |
| |
EU-Studie - Tankstellen
AIK - Kohlhaas & Partner
Konjunkturelle Rahmendaten, Tankstellen, 2008, nach Ländern der EU, Handels-Struktur und -Entwicklung, Anzahl der Unternehmen, Beschäftigten, Umsatz, Wareneinsatz und Vorratsverän
|
2011 |
480,00€ |
| |
EU-Studie - Einzelhandel mit Bodenbelägen, Tapeten und Vorhängen
AIK - Kohlhaas & Partner
Konjunkturelle Rahmendaten, Einzelhandel mit Bodenbelägen, Tapeten und Vorhängen, 2008, nach Ländern der EU, Handels-Struktur und -Entwicklung, Anzahl der Unternehmen, Beschäftigt
|
2011 |
480,00€ |
| |
EU-Studie - Einzelhandel mit Back- und Süßwaren
AIK - Kohlhaas & Partner
Konjunkturelle Rahmendaten, Einzelhandel mit Back- und Süßwaren, 2008, nach Ländern der EU, Handels-Struktur und -Entwicklung, Anzahl der Unternehmen, Beschäftigten, Umsatz, Waren
|
2011 |
480,00€ |
| |
EU-Studie - Kauf- und Warenhäuser
AIK - Kohlhaas & Partner
Konjunkturelle Rahmendaten, Kauf- und Warenhäuser, 2008, nach Ländern der EU, Handels-Struktur und -Entwicklung, Anzahl der Unternehmen, Beschäftigten, Umsatz, Wareneinsatz und Vo
|
2011 |
480,00€ |
| |
EU-Studie - Einzelhandel mit Fleisch und Fleischwaren
AIK - Kohlhaas & Partner
Konjunkturelle Rahmendaten, Einzelhandel mit Fleisch und Fleischwaren, 2008, nach Ländern der EU, Handels-Struktur und -Entwicklung, Anzahl der Unternehmen, Beschäftigten, Umsatz,
|
2011 |
480,00€ |
| |
EU-Studie - Einzelhandel mit Bürobedarf, Schreibwaren und Zeitschriften
AIK - Kohlhaas & Partner
Konjunkturelle Rahmendaten, Einzelhandel mit Bürobedarf, Schreibwaren und Zeitschriften, 2008, nach Ländern der EU, Handels-Struktur und -Entwicklung, Anzahl der Unternehmen, Besc
|
2011 |
480,00€ |
| |
EU-Studie - Einzelhandel mit Spielwaren
AIK - Kohlhaas & Partner
Konjunkturelle Rahmendaten, Einzelhandel mit Spielwaren, 2008, nach Ländern der EU, Handels-Struktur und -Entwicklung, Anzahl der Unternehmen, Beschäftigten, Umsatz, Wareneinsatz
|
2011 |
480,00€ |
| |
Company Financials: Asia Pacific Breweries Limited
Datamonitor
Scope / / *Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation / / *Provides key ratios / / *Includes information on revenue distribution by business segments and geographies / /
|
2011 |
75,00$ |
| |
Teva Pharma. Industries Ltd: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Teva in the prescription pharmaceutical sector. The profile encompasses global company strategy, po
|
2010 |
5.700,00$ |
| |
Alcon Inc.: PharmaVitae Profile
Alcon Inc.: pharmavitae Profil
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Alcon in the prescription pharmaceutical sector. The profile encompasses global company strategy, p
|
2010 |
5.700,00$ |
| |
Celgene Corporation: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Celgene in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
H. Lundbeck A/S: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Lundbeck in the prescription pharmaceutical sector. The profile encompasses global company strategy
|
2010 |
5.700,00$ |
| |
Pfizer Inc.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Pfizer in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
Watson Pharmaceuticals Inc.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Watson in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
AstraZeneca plc: PharmaVitae Profile
AstraZeneca plc: Pharmavitae Profil
Datamonitor
Introduction
This analysis examines the historical and forecast performance for AstraZeneca in the prescription pharmaceutical sector. The profile encompasses global company strat
|
2010 |
5.700,00$ |
| |
CSL Limited: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for CSL in the prescription pharmaceutical sector. The profile encompasses global company strategy, por
|
2010 |
5.700,00$ |
| |
Mylan Inc.: PharmaVitae Profile
Datamonitor
Introduction
The analysis examines the historical and forecast performance for Mylan in the generic prescription pharmaceutical sector. The profile encompasses global company str
|
2010 |
5.700,00$ |
| |
Shire plc: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Shire in the prescription pharmaceutical sector. The profile encompasses global company strategy, p
|
2010 |
5.700,00$ |
| |
Abbott Laboratories: PharmaVitae Profile
Abbott Laboratories: PharmaVitae Profil
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Abbott in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
Bristol-Myers Squibb Co.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Bristol-Myers Squibb in the prescription pharmaceutical sector. The profile encompasses global comp
|
2010 |
5.700,00$ |
| |
GlaxoSmithKline plc: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for GlaxoSmithKline in the prescription pharmaceutical sector. The profile encompasses global company s
|
2010 |
5.700,00$ |
| |
Otsuka Pharmaceutical Co., Ltd: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Otsuka in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
Warner-Chilcott Plc: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Warner Chilcott in the prescription pharmaceutical sector. The profile encompasses global company s
|
2010 |
5.700,00$ |
| |
Apotex Inc.: PharmaVitae Profile
Apotex Inc: PharmaVitae Profil
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Apotex in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Chugai in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
Merck & Co., Inc.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Merck & Co. in the prescription pharmaceutical sector. The profile encompasses global company strat
|
2010 |
5.700,00$ |
| |
Sanofi-Aventis: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Sanofi-Aventis in the prescription pharmaceutical sector. The profile encompasses global company st
|
2010 |
5.700,00$ |
| |
Boehringer Ingelheim GmbH: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Boehringer Ingelheim in the prescription pharmaceutical sector. The profile encompasses global comp
|
2010 |
5.700,00$ |
| |
Forest Laboratories Inc.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Forest in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
Novo Nordisk A/S: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Novo Nordisk in the prescription pharmaceutical sector. The profile encompasses global company stra
|
2010 |
5.700,00$ |
| |
UCB S.A.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for UCB in the prescription pharmaceutical sector. The profile encompasses global company strategy, por
|
2010 |
5.700,00$ |
| |
Allergan Inc.: PharmaVitae Profile
Allergan Inc.: PharmaVitae Profil
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Allergan in the prescription pharmaceutical sector. The profile encompasses global company strategy
|
2010 |
5.700,00$ |
| |
Cephalon Inc.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Cephalon in the prescription pharmaceutical sector. The profile encompasses global company strategy
|
2010 |
11.400,00$ |
| |
Johnson & Johnson: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Johnson & Johnson in the prescription pharmaceutical sector. The profile encompasses global company
|
2010 |
5.700,00$ |
| |
Baxter International Inc.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Baxter in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
Daiichi Sankyo Co., Ltd: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Daiichi Sankyo in the prescription pharmaceutical sector. The profile encompasses global company st
|
2010 |
5.700,00$ |
| |
Novartis AG: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Novartis in the prescription pharmaceutical sector. The profile encompasses global company strategy
|
2010 |
5.700,00$ |
| |
Sandoz International GmbH: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Sandoz in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
 MidAmerican Energy Acquires Stakes in the Topaz and Agua Caliente Solar PV Projects - Deal Analysis from GlobalData
GlobalData
Introduction
In December 2011, MidAmerican Energy acquired stakes in two ambitious solar power projects in the US. On December 7, 2011, MidAmerican Energy announced purchase of 10
|
2012 |
500,00$ |
| |
Quicksilver Resources Inc, Company Intelligence Report
GlobalData
Introduction
Quicksilver Resources Inc is an independent energy company engaged mainly in the exploration, development, and production of unconventional natural gas resources in t
|
2012 |
1.000,00$ |
| |
EXCO Resources Inc, Company Intelligence Report
GlobalData
Introduction
EXCO Resources, Inc. (EXCO) is an independent crude oil and natural gas company, and was established in October 1955. The e company is headquartered in Dallas, Texas.
|
2012 |
1.000,00$ |
| |
Sea Dragon to Acquire National Petroleum Company Egypt for $147.5m - Sea Dragon’s Step to Expand Operations in Egypt - Deal Analysis from GlobalData
GlobalData
Introduction
Sea Dragon Energy Inc.(Sea Dragon), an oil and gas company, through its indirect wholly owned subsidiary, agreed to acquire all of the issued and outstanding shares o
|
2012 |
500,00$ |
| |
Goodrich Petroleum Corporation, Company Intelligence Report
GlobalData
Introduction
Goodrich Petroleum Corporation (Goodrich) is an independent oil and gas company engaged in the exploration, exploitation, development and production of oil and natura
|
2012 |
1.000,00$ |
| |
Google And KKR Complete Project Financing for the Acquisition of Solar PV Power Portfolio from Recurrent Energy - Deal Analysis from GlobalData
GlobalData
Introduction
Google Inc, the internet search company, and Kohlberg Kravis Roberts & Co. L.P. (KKR), a global investment firm, completed project financing for the acquisition of fo
|
2012 |
500,00$ |
| |
Fayetteville Shale in the US, 2011 - Gas Shale Market Analysis and Forecasts to 2020
GlobalData
Introduction
“Fayetteville Shale in the US, 2011 - Gas Shale Market Analysis and Forecasts to 2020” is the latest report from GlobalData, the industry analysis specialist, which p
|
2012 |
1.500,00$ |
| |
Sesa Goa Acquires Additional 1.5% Stake in Cairn India for $181.3m - Sesa Goa Acquired to Have an Access to India’s Best Oil Assets - Deal Analysis from GlobalData
GlobalData
Introduction
Sesa Goa Limited (Sesa Goa), a producer and exporter of iron ore, acquired an additional 28,807,241 shares, representing approximately 1.5% of the total paid up share
|
2012 |
500,00$ |
| |
| Firmenprofile / SWOT Reports angezeigte Produkte: 1 bis 50 (von 58308 insgesamt) |
|
| Seiten: 1 |
|
|
